Adenosquamous carcinoma of the lung
Jump to navigation
Jump to search
Adenosquamous carcinoma of the lung is a rare epithelial derived malignancy of the lung with features of both adenocarcinoma and squamous cell carcinoma.
General
- Respond to tyroxine kinase inhibitors.[1]
Microscopic
Features:
- Adenocarcinoma component.
- Squamous cell carcinoma component.
See also
References
- ↑ Song, Z.; Lin, B.; Shao, L.; Zhang, Y. (Sep 2013). "Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.". J Chin Med Assoc 76 (9): 481-5. doi:10.1016/j.jcma.2013.05.007. PMID 23769878.